Recruiting Clinical Trials

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 6

Age Group: 18 Years to 75 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: FAPME-1

Study First Received: October 31, 2012

Last Updated: May 10, 2016

Estimated Primary Completion Date: December 2016

 

Primary Outcome Measures:

Safety

Sponsors and Collaborators:

University of Zurich

Website Link: https://ClinicalTrials.gov/show/NCT01722149

Leave a Reply

Call Now